A long term, non-interventional study investigating the effect of imatinib in gastrointestinal stroma tumours (GIST) after R0/R1 resection patients

Trial Profile

A long term, non-interventional study investigating the effect of imatinib in gastrointestinal stroma tumours (GIST) after R0/R1 resection patients

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 08 Dec 2015

At a glance

  • Drugs Imatinib (Primary)
  • Indications Gastrointestinal stromal tumours
  • Focus Therapeutic Use
  • Acronyms LOGIST
  • Most Recent Events

    • 08 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top